Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.
about
Type III Interferons in Hepatitis C Virus Infection.Treatment discontinuation with peg-interferon: what to consider.Is the benefit of treating patients with cirrhosis proven?Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1Patients Treated by Pegylated Interferon and RibavirinHelicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism.
P2860
Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Interferon lambda-3 is not ass ...... sis: a long-term cohort study.
@en
type
label
Interferon lambda-3 is not ass ...... sis: a long-term cohort study.
@en
prefLabel
Interferon lambda-3 is not ass ...... sis: a long-term cohort study.
@en
P2093
P50
P1433
P1476
Interferon lambda-3 is not ass ...... sis: a long-term cohort study.
@en
P2093
Alex J Thompson
Andrea Crosignani
Paola Zermiani
Rosina Critelli
Sonia Rossi
Stefania De Lisi
Vincenzo Boccaccio
P356
10.1016/J.ANTIVIRAL.2014.11.002
P577
2014-11-11T00:00:00Z